XML 45 R28.htm IDEA: XBRL DOCUMENT
v3.21.1

REVENUE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
REVENUE |
Schedule of Company's disaggregation of revenues | The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
(U.S. dollars in thousands) | ​ | 2018 | ​ | 2019 |  | 2020
Pfizer | ​ | $ | 5,320 | ​ | $ | 6,722 | ​ | $ | 8,105
Brazil | ​ | $ | 3,658 | ​ | $ | 9,144 | ​ | $ | 8,000
Chiesi | ​ | ​ | - | ​ | ​ | - | ​ | $ | 131
Total revenues from selling goods | ​ | $ | 8,978 | ​ | $ | 15,866 | ​ | $ | 16,236
Revenues from license and R&D services | ​ | $ | 25,262 | ​ | $ | 38,827 | ​ | $ | 46,662

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration